MADISON, N.J., Feb. 22, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will showcase its Quanum™ suite of healthcare information technology (HIT) solutions, including Data Diagnostics with Inovalon, at  the HIMSS16 Annual Conference & Exhibition, to be held February 29 - March 3, 2016 in Las Vegas, Nevada (Quest Diagnostics Booth 2754). Quanum™ is a new brand that reflects how Quest Diagnostics helps people analyze, connect and engage with healthcare information technology to deliver better patient care.

"As the leader in diagnostic information services, we are in a unique position to connect patients, providers, payers and ACOs with actionable insights based on lab, clinical, quality, claims and other health data," said Steve Rusckowski, president and CEO, Quest Diagnostics. "Our Quanum suite of HIT solutions reflects this new way of thinking about Quest and our broader ability to harness insights and technology to deliver better healthcare.  Quest's national connectivity, big data, technology and clinical expertise uniquely position us to provide the kinds of technology solutions that will improve quality, lower costs, engage patients and optimize financial performance."

Quanum includes a suite of healthcare information technology and analytics tools that allow patients, private and public payers, ACOs, large health systems and clinicians to analyze, connect and engage, improving quality and health outcomes. The suite features Data Diagnostics™, a real-time point of care analytics technology that Quest introduced in late 2015 with Inovalon, a leading technology company providing advanced, cloud-based data analytics and data-driven intervention platforms to the healthcare industry. The two companies will showcase Data Diagnostics with live demonstrations and an educational session (Wednesday, March 2 at 2:30 pm PT) at the conference.

"Our Quanum solutions are built on assets that only Quest possesses as the leader in our industry," said Lidia L. Fonseca, senior vice president and chief information officer, Quest Diagnostics. "These include Quest's ability to generate insights from our industry-leading dataset of 20 billion test results as well as connectivity with 400 EHRs and about half of the physicians and hospitals in the U.S. Quanum solutions are infused with our deep experience in healthcare, enabling patients, providers and payers to act on data-driven insights to improve outcomes and lower costs.

"From the patient seeking to understand her health records to the ACO executive who wants to manage a population more effectively, our Quanum solutions help people take actions leading to healthier lives," Ms. Fonseca said.

Quanum Technology Suite Aims to Deliver Better Outcomes for Lower Costs

Additional Quanum technologies include:  

• Care360™ Suite, Quest's Care360 product suite includes Care360 laboratory connectivity and prescription drug prescribing platforms as well as a cloud-based electronic health record (EHR), which features robust practice management and billing tools. More than 420,000 physicians use Care360 products to order and receive laboratory testing and manage related health data. Approximately 2 million patients use the myQuest by Care360™ mobile patient app and portal to track and securely access their personal health information including lab results, prescriptions and medical history.  
• Interactive Insights™, Quest's next-generation lab reporting solution, is a web-based result view that provides laboratory results, enhanced with diagnostic insights, in both provider and patient contexts.  The technology, available to Care360 users in select markets, is designed to provide meaningful context to lab results and enhance the ability of physicians to educate patients in actions they can take for better outcomes. Interactive Insights is also available via Change Healthcare's Clinical Network solution in select markets.
• In addition, Quanum includes clinical analytics, population health and test utilization tools. These tools provide insights based on Quest's lab data to help hospital health systems, health plans, ACOs and other health care entities track utilization, assess gaps in care, evaluate clinical protocol effectiveness and take other actions to improve outcomes and lower costs.

Quest Diagnostics Solutions on Display at HIMSS16 (Booth 2754) 
Quest will showcase key products from the Quanum suite, including Data Diagnostics, Care360 and Interactive Insights, at this year's HIMSS conference. In addition, Quest's award-winning ChartMaxx® portfolio of enterprise-content management solutions will also be shown at HIMSS. ChartMaxx enables healthcare organizations to capture, manage, store and deliver clinical and non-clinical business data and documents content. Awarded top document management system by KLAS more than any other provider, ChartMaxx is used by approximately 250 hospitals and integrated healthcare delivery networks (IDNs) with more than half a million users.

Quest and Inovalon Experts To Discuss Power of Real-Time Analytics
At HIMSS, Quest and Inovalon experts will host a session titled, "The Power of Real-Time Analytics at the Point of Care" on Wednesday, March 2 at 2:30 pm PT on Level 1 in the Galileo 1001 Room of the Sands Expo and Convention Center.

For more information, visit Quest Diagnostics HIMSS16.

About Quest Diagnostics 
Quest Diagnostics is the world's leading provider of diagnostic information services needed to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.

Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.

Contacts: 
Wendy Bost, Quest Diagnostics (Media): 973-520-2800 
Jenny Dudikoff, K P (Media at HIMSS): 916-224-9429 
Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900

Logo - http://photos.prnewswire.com/prnh/20150422/200883LOGO

SOURCE Quest Diagnostics